Radial access offers more patient satisfaction¹
3
neutrals-100
This alternative approach offers distinct advantages over transfemoral access, including enhanced patient comfort, faster mobilisation/ambulation, fewer access site complications, and potentially shorter hospital stays and reduced costs. With technological advancements enabling broader clinical applications, radial access is increasingly being adopted by interventional radiologists for peripheral interventions, including visceral (R2V) procedures—unlocking new possibilities in patient-centered care.2
neutrals-100
false
true
Clinical Evidence
2
neutrals-100
Emerging clinical evidence indicates that R2V is a feasible and effective alternative access approach for multiple abdominal endovascular therapeutic targets.2 Large retrospective studies3 and mid-sized prospective registries4 report high technical success rates (97–98%)3,4 and a very low incidence of major complications (0–0.13%).3,4 Notably, no cases of hand ischemia or clinically significant neurological events have been reported3,4 supporting the safety of R2V across a range of vascular procedures. R2V is also associated with greater patient preference compared to femoral access, as indicated by randomized trial results.1 However, careful patient assessment and selection remain essential to minimize possible risks and optimize outcomes.2
neutrals-100
pd-y-64

State of the art devices

Expand your access and delivery capabilities for therapeutic interventions

RADIFOCUS™ Glidecath™ R.A.V.I.* MG1 and MG2 tip shapes specifically designed for radial access provides you with the performance required for visceral interventions, including pelvic procedures​.

  • Trackability - Traverse tortuous anatomy while leveraging on its ability to deliver devices through a nylon rich inner layer5,6.
  • Torqueability - Engage acute vessels with good torque control with a double-braided design5,6.
  • Lubricity​ - Navigate difficult vasculature with great lubricity provided by M Coat™ Technology​5,6.

* R.A.V.I : Radial Access for Visceral Intervention

grid-texts-40
text-vertical-top
image-media-type
aspect-ratio-4-3
media-left
What the evidence says
3
neutrals-100
Discover our clinical evidence and case studies concerning this topic.
neutrals-100
terumo-product-tag:occlusafe™,terumo-product-tag:glidesheath-slender™,terumo-product-tag:tr-band™
Featured products
2
neutrals-100
References
2
neutrals-100
text
Yamada R et al. JVIR 2018; 29:38-43
text
Kovacic J.C. et al. JVIR 2024; 18(1):91-101
text
Posham et al. JVIR 2016; 27:159-166
text
text
Guimaraes M. et al. CVIR Endov. 2024; 7:15
text
When compared to leading competitors
The video above ​is a recording of the webinar 'Beyond cardiology - transradial access and visceral intervention'​ to allow healthcare professionals to watch the event on demand. This recording is to be used for training purposes only and in no case intended for the general public. Any claims and views expressed in this video reflect solely the speaker's own experiences or opinions and do not necessarily reflect the position of Terumo. No part of the recording may be reproduced, distributed, transmitted in any form or by any means, electronic or manually, without the prior written consent of Terumo Europe NV.
neutrals-100